Bellevue Group AG - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 1.2%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2020$486,000
-7.3%
4,5000.0%0.01%
+12.5%
Q4 2019$524,000
+1.7%
4,5000.0%0.01%
-20.0%
Q3 2019$515,000
+49.7%
4,500
+24.7%
0.01%
+66.7%
Q2 2019$344,0003,6090.01%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q4 2019
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 149,457$11,773,0006.29%
INDUS CAPITAL PARTNERS, LLC 330,339$26,021,0002.54%
Perpetual Ltd 129,799$10,215,0001.32%
Black Creek Investment Management Inc. 396,525$31,234,0001.18%
RUDMAN ERROL M 28,701$2,261,0001.10%
COMGEST GLOBAL INVESTORS S.A.S. 635,752$50,078,0001.09%
Antipodean Advisors LLC 15,000$1,182,0000.96%
Hillhouse Capital Management 618,391$48,711,0000.83%
JUPITER ASSET MANAGEMENT LTD 215,866$17,004,0000.49%
Temasek Holdings (Private) Ltd 990,000$77,982,0000.48%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders